American Society of Hirudotherapy

Ethiopian Food and Drug Authority

EFDA · Ethiopia · africa

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Ethiopia's Food and Drug Authority — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general national medical device framework or traditional-medicine pathways as appropriate.

Regulatory Profile

Agency type
national regulator
Region
africa
Country
Ethiopia
Leech status
unregulated
Last ASH review
2026-05-26

Relevant Regulation Codes

  • Ethiopian Food and Medicine Administration Proclamation No. 1112/2019
  • Ethiopian national medical device regulatory framework

Prescriber Requirements

  • Ethiopian Medical Association / regional health bureau–registered physician — order required for any biomedical device application
  • Traditional medicine practitioners may have separate scope under national traditional medicine policy; specific hirudotherapy authorisation not independently verified by ASH

Supply Chain & GMP

EFDA registration as applicable; English and Amharic-language labelling. Standard cold-chain conditions, with logistical constraints typical for sub-Saharan distribution.

Import/Export Rules

EFDA import authorisation; Ministry of Agriculture / veterinary services clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Not covered under public insurance schemes for leech therapy specifically.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. Ethiopia maintains a national traditional medicine policy alongside biomedical regulation; whether hirudotherapy is captured by either has not been independently mapped by ASH.

Related Jurisdictions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.